相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammalian Target of Rapamycin: Its Role in Early Neural Development and in Adult and Aged Brain Function
Carla Garza-Lombo et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Sunitinib induces PTEN expression and inhibits PDGFR signaling and migration of medulloblastoma cells
Thamara J. Abouantoun et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Long-term exposure of leukemia cells to multi-targeted tyrosine kinase inhibitor induces activations of AKT, ERK and STAT5 signaling via epigenetic silencing of the PTEN gene
C. Nishioka et al.
LEUKEMIA (2010)
Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene
Toshirou Nishida et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2009)
The drug-resistance to gefitinib in PTEN low expression cancer cells is reversed by irradiation in vitro
Hong-Qing Zhuang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Multitargeted tyrosine kinase inhibitor stimulates expression of IL-6 and activates JAK2/STAT5 signaling in acute myelogenous leukemia cells
C. Nishioka et al.
LEUKEMIA (2009)
Molecular pathobiology of gastrointestinal stromal sarcomas
Christopher L. Corless et al.
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE (2008)
Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT
Charles D. Blanke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033
Charles D. Blanke et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Restoration of PTEN expression alters the sensitivity of prostate cancer cells to EGFR inhibitors
Z. Wu et al.
PROSTATE (2008)
KIT oncogenic signaling mechanisms in imatinib-resistant gastrointestinal stromal tumor: PI3-kinase/AKT is a crucial survival pathway
S. Bauer et al.
ONCOGENE (2007)
Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial
George D. Demetri et al.
LANCET (2006)
Effect of SU11248 on gastrointestinal stromal tumor-T1 cells: Enhancement of growth inhibition via inhibition of 3-kinase/Akt/mammalian target of rapamycin signaling
Takayuki Ikezoe et al.
CANCER SCIENCE (2006)
HIV-1 protease inhibitor ritonavir potentiates the effect of 1,25-dihydroxyvitamin D3 to induce growth arrest and differentiation of human myeloid leukemia cells via down-regulation of CYP24
Takayuki Ikezoe et al.
LEUKEMIA RESEARCH (2006)
Efficacy of the kinase inhibitor SU11248 against gastrointestinal stromal tumor mutants refractory to imatinib mesylate
H Prenen et al.
CLINICAL CANCER RESEARCH (2006)
PTEN promoter methylation in sporadic thyroid carcinomas
F Alvarez-Nunez et al.
THYROID (2006)
Gastrointestinal stromal tumors in Iceland, 1990-2003:: The Icelandic GIST study, a population-based incidence and pathologic risk stratification study
G Tryggvason et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases
TA Carter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
HIV-1 protease inhibitor induces growth arrest and apoptosis of human prostate cancer LNCaP cells in vitro and in vivo in conjunction with blockade of androgen receptor STAT3 and AKT signaling
Y Yang et al.
CANCER SCIENCE (2005)
Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation
CR Antonescu et al.
CLINICAL CANCER RESEARCH (2005)
Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA)
Y Kokubo et al.
BRITISH JOURNAL OF CANCER (2005)
Gastrointestinal stromal tumors:: The incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era -: A population-based study in western Sweden
B Nilsson et al.
CANCER (2005)
Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor
T Taguchi et al.
LABORATORY INVESTIGATION (2002)
Diagnosis of gastrointestinal stromal tumors: A consensus approach
CDM Fletcher et al.
HUMAN PATHOLOGY (2002)
KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size
CL Corless et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.
H Joensuu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival
RP DeMatteo et al.
ANNALS OF SURGERY (2000)
分享论文
